PetVivo Holdings, Inc., is an emerging biomedical device company focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. It is also engaging in the veterinary market to treat and/or manage afflictions of companion animals such as cats, dogs and horses. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company’s pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. is headquartered in Edina, Minnesota.